Lipitor, also known as atorvastatin, is a medication used to lower cholesterol levels in the body. According to the FDA, changes in Lipitor dosage should be made based on the individual's response to treatment and the goal of therapy [3]. The British Heart Foundation recommends that the starting dose for Lipitor is 10 mg daily and that the dose can be increased after four weeks if necessary [2]. It is important to note that dosage adjustments should be made under the guidance of a healthcare professional.

Regular monitoring of cholesterol levels is recommended while taking Lipitor to ensure that the medication is effectively lowering cholesterol levels. The FDA recommends that healthcare professionals perform liver function tests before initiating treatment with Lipitor and as clinically indicated thereafter [3]. Additionally, the British Heart Foundation suggests that cholesterol levels should be checked four to six weeks after starting treatment and then every six to 12 months thereafter [2].

In 2012, the FDA issued a safety communication regarding important safety label changes for cholesterol-lowering statin drugs, including Lipitor. The label changes included information about the potential risks of increased blood sugar levels, memory loss, and muscle damage associated with statin use [3]. It is important for individuals taking Lipitor to be aware of these risks and to report any concerning symptoms to their healthcare provider.

In summary, changes in Lipitor dosage should be made based on individual response to treatment and under the guidance of a healthcare professional. Regular monitoring of cholesterol levels and liver function tests are recommended while taking Lipitor. The starting dose for Lipitor is typically 10 mg daily, with the option to increase the dose after four weeks if necessary. Individuals taking Lipitor should also be aware of the potential risks associated with statin use and report any concerning symptoms to their healthcare provider.

Sources:
[2] British Heart Foundation. (n.d.). Statins. Retrieved from https://www.bhf.org.uk/informationsupport/heart-matters-magazine/medical/drug-cabinet/statins
[3] U.S. Food and Drug Administration. (2012). FDA drug safety communication: Important safety label changes to cholesterol-lowering statin drugs. Retrieved from https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-important-safety-label-changes-cholesterol-lowering-statin-drugs
[4] DrugPatentWatch. (n.d.). Lipitor. Retrieved from https://www.drugpatentwatch.com/p/tradename/LIPITOR